Prestige Consumer Healthc... (PBH)
Prestige Consumer Healthcare Statistics
Share Statistics
Prestige Consumer Healthcare has 49.54M shares outstanding. The number of shares has increased by -0.58% in one year.
Shares Outstanding | 49.54M |
Shares Change (YoY) | -0.58% |
Shares Change (QoQ) | -0.31% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 48.94M |
Failed to Deliver (FTD) Shares | 33 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.33M, so 4.72% of the outstanding shares have been sold short.
Short Interest | 2.33M |
Short % of Shares Out | 4.72% |
Short % of Float | 4.78% |
Short Ratio (days to cover) | 8.67 |
Valuation Ratios
The PE ratio is 17.04 and the forward PE ratio is 16.63. Prestige Consumer Healthcare's PEG ratio is -0.05.
PE Ratio | 17.04 |
Forward PE | 16.63 |
PS Ratio | 3.17 |
Forward PS | 3.6 |
PB Ratio | 2.15 |
P/FCF Ratio | 14.9 |
PEG Ratio | -0.05 |
Enterprise Valuation
Prestige Consumer Healthcare Inc. has an Enterprise Value (EV) of 4.49B.
EV / Earnings | 21.45 |
EV / Sales | 3.99 |
EV / EBITDA | 12.01 |
EV / EBIT | 13.12 |
EV / FCF | 18.76 |
Financial Position
The company has a current ratio of 3.2, with a Debt / Equity ratio of 0.69.
Current Ratio | 3.2 |
Quick Ratio | 2.02 |
Debt / Equity | 0.69 |
Total Debt / Capitalization | 40.78 |
Cash Flow / Debt | 0.22 |
Interest Coverage | 5.1 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 9.29%.
Return on Equity (ROE) | 0.13% |
Return on Assets (ROA) | 0.06% |
Return on Capital (ROIC) | 9.29% |
Revenue Per Employee | $1,974,310.53 |
Profits Per Employee | $367,261.4 |
Employee Count | 570 |
Asset Turnover | 0.34 |
Inventory Turnover | 3.61 |
Taxes
Income Tax | 66.69M |
Effective Tax Rate | 0.24 |
Stock Price Statistics
The stock price has increased by 17.03% in the last 52 weeks. The beta is 0.46, so Prestige Consumer Healthcare's price volatility has been higher than the market average.
Beta | 0.46 |
52-Week Price Change | 17.03% |
50-Day Moving Average | 82.77 |
200-Day Moving Average | 75.84 |
Relative Strength Index (RSI) | 52.73 |
Average Volume (20 Days) | 325.53K |
Income Statement
In the last 12 months, Prestige Consumer Healthcare had revenue of 1.13B and earned 209.34M in profits. Earnings per share was 4.21.
Revenue | 1.13B |
Gross Profit | 624.45M |
Operating Income | 342.43M |
Net Income | 209.34M |
EBITDA | 373.86M |
EBIT | 342.43M |
Earnings Per Share (EPS) | 4.21 |
Balance Sheet
The company has 46.47M in cash and 1.14B in debt, giving a net cash position of -1.09B.
Cash & Cash Equivalents | 46.47M |
Total Debt | 1.14B |
Net Cash | -1.09B |
Retained Earnings | 1.34B |
Total Assets | 3.33B |
Working Capital | 274.62M |
Cash Flow
In the last 12 months, operating cash flow was 248.93M and capital expenditures -9.55M, giving a free cash flow of 239.38M.
Operating Cash Flow | 248.93M |
Capital Expenditures | -9.55M |
Free Cash Flow | 239.38M |
FCF Per Share | 4.81 |
Margins
Gross margin is 55.49%, with operating and profit margins of 30.43% and 18.6%.
Gross Margin | 55.49% |
Operating Margin | 30.43% |
Pretax Margin | 24.53% |
Profit Margin | 18.6% |
EBITDA Margin | 33.22% |
EBIT Margin | 30.43% |
FCF Margin | 21.27% |
Dividends & Yields
PBH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 4.95% |
FCF Yield | 5.68% |
Analyst Forecast
The average price target for PBH is $98.5, which is 15.9% higher than the current price. The consensus rating is "Buy".
Price Target | $98.5 |
Price Target Difference | 15.9% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | 3.03 |
Piotroski F-Score | 7 |